Patents by Inventor Mark Rieder

Mark Rieder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
    Patent number: 11047008
    Abstract: Methods are provided for predicting a subject's infection status using high-throughput T cell receptor sequencing to match the subject's TCR repertoire to a known set of disease-associated T cell receptor sequences. The methods of the present invention may be used to predict the status of several infectious agents in a single sample from a subject. Methods are also provided for predicting a subject's HLA status using high-throughput immune receptor sequencing.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: June 29, 2021
    Assignees: Adaptive Biotechnologies Corporation, Fred Hutchinson Cancer Research Center
    Inventors: Ryan O. Emerson, Harlan S. Robins, Mark Rieder, William Dewitt, III, Christopher Carlson
  • METHODS FOR DIAGNOSING INFECTIOUS DISEASE AND DETERMINING HLA STATUS USING IMMUNE REPERTOIRE SEQUENCING
    Publication number: 20180037953
    Abstract: Methods are provided for predicting a subject's infection status using high-throughput T cell receptor sequencing to match the subject's TCR repertoire to a known set of disease-associated T cell receptor sequences. The methods of the present invention may be used to predict the status of several infectious agents in a single sample from a subject. Methods are also provided for predicting a subject's HLA status using high-throughput immune receptor sequencing.
    Type: Application
    Filed: February 24, 2016
    Publication date: February 8, 2018
    Inventors: Ryan O. Emerson, Harlan S. Robins, Mark Rieder, William Dewitt, III, Christopher Carlson
  • METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
    Publication number: 20080057500
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: March 16, 2007
    Publication date: March 6, 2008
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark RIEDER, Allan RETTIE
  • METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
    Publication number: 20080050733
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: March 16, 2007
    Publication date: February 28, 2008
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark RIEDER, Allan RETTIE
  • METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
    Publication number: 20080050732
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: March 16, 2007
    Publication date: February 28, 2008
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark Rieder, Allan Rettie
  • Methods and compositions for predicting drug responses
    Publication number: 20060084081
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on the level of expression of the VKORC1 gene.
    Type: Application
    Filed: May 31, 2005
    Publication date: April 20, 2006
    Applicant: University of Washington
    Inventors: Mark Rieder, Allan Rettie
  • Methods and compositions for predicting drug responses
    Publication number: 20060084070
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: October 18, 2004
    Publication date: April 20, 2006
    Applicant: The University of Washington
    Inventors: Mark Rieder, Allan Rettie